294 related articles for article (PubMed ID: 16126395)
1. Dihydropyrido[2,3-d]pyrimidines as a new class of antileishmanial agents.
Agarwal A; Ramesh ; Ashutosh ; Goyal N; Chauhan PM; Gupta S
Bioorg Med Chem; 2005 Dec; 13(24):6678-84. PubMed ID: 16126395
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antileishmanial activity of novel 2,4,6-trisubstituted pyrimidines and 1,3,5-triazines.
Sunduru N; Nishi ; Palne S; Chauhan PM; Gupta S
Eur J Med Chem; 2009 Jun; 44(6):2473-81. PubMed ID: 19217698
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of marine alkaloid: 8,9-dihydrocoscinamide B and its analogues as Novel class of antileishmanial agents.
Gupta L; Talwar A; Nishi ; Palne S; Gupta S; Chauhan PM
Bioorg Med Chem Lett; 2007 Jul; 17(14):4075-9. PubMed ID: 17548194
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antileishmanial profile of some novel terpenyl pyrimidines.
Pandey S; Suryawanshi SN; Gupta S; Srivastava VM
Eur J Med Chem; 2004 Nov; 39(11):969-73. PubMed ID: 15501546
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of new [1,2,4]triazino[5,6-b]indol-3-ylthio-1,3,5-triazines and [1,2,4]triazino[5,6-b]indol-3-ylthio-pyrimidines against Leishmania donovani.
Gupta L; Sunduru N; Verma A; Srivastava S; Gupta S; Goyal N; Chauhan PM
Eur J Med Chem; 2010 Jun; 45(6):2359-65. PubMed ID: 20371140
[TBL] [Abstract][Full Text] [Related]
6. Antileishmanial agents part-IV: synthesis and antileishmanial activity of novel terpenyl pyrimidines.
Chandra N; Ramesh ; Ashutosh ; Goyal N; Suryawanshi SN; Gupta S
Eur J Med Chem; 2005 Jun; 40(6):552-6. PubMed ID: 16003841
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of 2-pyridyl pyrimidines with in vitro antiplasmodial and antileishmanial activity.
Musonda CC; Whitlock GA; Witty MJ; Brun R; Kaiser M
Bioorg Med Chem Lett; 2009 Jan; 19(2):401-5. PubMed ID: 19091562
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of chromenochalcones and evaluation of their in vitro antileishmanial activity.
Narender T; Khaliq T; Shweta ; Nishi ; Goyal N; Gupta S
Bioorg Med Chem; 2005 Dec; 13(23):6543-50. PubMed ID: 16185885
[TBL] [Abstract][Full Text] [Related]
9. A pyrimidine-beta-carboline and other alkaloids from Annona foetida with antileishmanial activity.
Costa EV; Pinheiro ML; Xavier CM; Silva JR; Amaral AC; Souza AD; Barison A; Campos FR; Ferreira AG; Machado GM; Leon LL
J Nat Prod; 2006 Feb; 69(2):292-4. PubMed ID: 16499336
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of 2,4,6-trisubstituted pyrimidine and triazine heterocycles as antileishmanial agents.
Sunduru N; Agarwal A; Katiyar SB; Nishi ; Goyal N; Gupta S; Chauhan PM
Bioorg Med Chem; 2006 Dec; 14(23):7706-15. PubMed ID: 16945542
[TBL] [Abstract][Full Text] [Related]
11. Arylanthranilodinitriles: a new biaryl class of antileishmanial agents.
Singh FV; Vatsyayan R; Roy U; Goel A
Bioorg Med Chem Lett; 2006 May; 16(10):2734-7. PubMed ID: 16503140
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of aryl pyrimidine derivatives as potential leishmanicidal agents.
Suryawanshi SN; Kumar S; Shivahare R; Pandey S; Tiwari A; Gupta S
Bioorg Med Chem Lett; 2013 Sep; 23(18):5235-8. PubMed ID: 23910597
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy of leishmaniasis part III: synthesis and bioevaluation of novel aryl substituted terpenyl pyrimidines as antileishmanial agents.
Chandra N; Pandey S; Ramesh ; Suryawanshi SN; Gupta S
Eur J Med Chem; 2006 Jun; 41(6):779-85. PubMed ID: 16697490
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of new furanyl and thiophenyl azoles as antileishmanial agents.
Marrapu VK; Mittal M; Shivahare R; Gupta S; Bhandari K
Eur J Med Chem; 2011 May; 46(5):1694-700. PubMed ID: 21385661
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy of leishmaniasis part-VIII: synthesis and bioevaluation of novel chalcones.
Suryawanshi SN; Chandra N; Kumar P; Porwal J; Gupta S
Eur J Med Chem; 2008 Nov; 43(11):2473-8. PubMed ID: 18243420
[TBL] [Abstract][Full Text] [Related]
16. Preparation and antileishmanial activity of lipophilic N-alkyl diamines.
da Costa CF; Coimbra ES; Braga FG; dos Reis RC; da Silva AD; de Almeida MV
Biomed Pharmacother; 2009 Jan; 63(1):40-2. PubMed ID: 18262385
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antileishmanial activity of some 1- or 2-(dihydroxyalkyl) and 3-(dihydroxyalkoxy)pyrazolo [3,4-d] pyrimidines.
Gatta F; Gradoni L; Lupardini E; Gramiccia M; Orsini S
Farmaco; 1991 Jan; 46(1):75-84. PubMed ID: 2054043
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, analytical behaviour and biological evaluation of new 4-substituted pyrrolo[1,2-a]quinoxalines as antileishmanial agents.
Guillon J; Forfar I; Mamani-Matsuda M; Desplat V; Saliège M; Thiolat D; Massip S; Tabourier A; Léger JM; Dufaure B; Haumont G; Jarry C; Mossalayi D
Bioorg Med Chem; 2007 Jan; 15(1):194-210. PubMed ID: 17049253
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of substituted aryloxy alkyl and aryloxy aryl alkyl imidazoles as antileishmanial agents.
Bhandari K; Srinivas N; Marrapu VK; Verma A; Srivastava S; Gupta S
Bioorg Med Chem Lett; 2010 Jan; 20(1):291-3. PubMed ID: 19913413
[TBL] [Abstract][Full Text] [Related]
20. Syntheses of new substituted triazino tetrahydroisoquinolines and beta-carbolines as novel antileishmanial agents.
Kumar A; Katiyar SB; Gupta S; Chauhan PM
Eur J Med Chem; 2006 Jan; 41(1):106-13. PubMed ID: 16356594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
